Search Results

Nanowear has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD).

Nanowear www.nanowearinc.com, the leading nanotechnology and A.I.-based remote diagnostic company, today announced a commercial distribution partnership with a world leading aesthetic and reconstructive surgical device-manufacturer, to enhance and optimize post-surgical recovery for both patients and surgeons.

Nanowear, a leading hospital-at-home and remote diagnostic platform informed by proprietary cloth nanotechnology and AI, today announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform, illustrating unique capabilities available to enterprise customer channels across a broad spectrum of diagnostic and monitoring verticals.

Nanowear www.nanowearinc.com, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform, SimpleSENSE.

Nanowear www.nanowearinc.com , the leading nanotechnology-based connected-care and remote diagnostic platform, today announced an expanded COVID-19 remote diagnostic research alliance with Hackensack Meridian Health Systems, the largest hospital system in New Jersey and Maimonides Medical Center in Brooklyn, NY .

Nanowear, the leading nanotechnology-based connected-care and remote monitoring platform, today announced the clinical launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

Under the terms of the agreement, Nanowear and The Secant Group will have the collective obligation for marketing the technology and associated products.

Call for applications to foster next-generation technology and innovation in the healthcare industry